A National Institutes of Health (NIH)-supported clinical trial has found that intravenous acetaminophen reduced sepsis patients’ risk of having organ injury or developing acute respiratory distress syndrome, a serious condition that allows fluid to leak into the lungs.
Another Eylea threat: Roche expands label for blockbuster eye drug Vabysmo
With hopes of dethroning Regeneron’s blockbuster eye drug franchise Eylea, Roche on Thursday announced the FDA has expanded the label of its own blockbuster eye
October 28, 2023